- ADYNOVATE® Prescribing Information.
- Mullins ES, Stasyshyn O, Alvarez-Román MT, et al. Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A. Haemophilia. 2016 Nov 27. doi:10.1111/hae.13119 [Epub ahead of print].
- Data on File; Shire US Inc.
- Interquartile Range definition. MedlinePlus. https://www.merriam-webster.com/dictionary/interquartile%20range. Accessed December 5, 2016.
- Konkle BA, Stasyshyn O, Chowdary P, et al. PEGylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A. Blood. 2015;126(9):1078-1085.
- Turecek PL, Bossard MJ, Graninger M, et al. BAX 855, a PEGylated rFVIII product with prolonged half-life: development, functional and structural characterisation. Hämostaseologie. 2012;32(Suppl 1): S29-S38.
- Milla P, Dosio F, Cattel L. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab. 2012;13(1):105-119.
- Brand B, Gruppo R, Wynn TT, et al. Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients. Haemophilia. 2016;22(4):e251-e258.
- ADVATE® Prescribing Information.
- Kingdon HS, Lundblad RL. An adventure in biotechnology: the development of haemophilia A therapeutics – from whole-blood transfusion to recombinant DNA to gene therapy. Biotechnol Appl Biochem. 2002;35:141-148.
- Farb et al. Method of purifying factor VIII-C. U.S. Patent 4,758,657. July 19, 1988. http://www.freepatentsonline.com/5470954.html. Accessed December 14, 2016.
- Leveton LB, Sox HC Jr, Stoto MA, eds. Committee to Study HIV Transmission Through Blood and Blood Products, Institute of Medicine. HIV and the Blood Supply: An Analysis of Crisis Decisionmaking. National Academies Press;1995. http://www.nap.edu/catalog/4989.html
- U.S. Food & Drug Administration. User fee billable biologic product and potencies approved under section 351 of the PHS Act. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/ucm122936.htm. Accessed December 14, 2016.
- Harvard Business School. Lehman Brothers Collection. Baxter Laboratories, Inc. 2012. http://www.library.hbs.edu/hc/lehman/company.html?company=baxter_laboratories_inc. Accessed December 14, 2016.
- Bertolini J, Goss N, Curling J. Production of Plasma Proteins for Therapeutic Use. John Wiley & Sons. http://www.wiley.com/ WileyCDA/WileyTitle/productCd-0470924314.html. Accessed December 14, 2016.
No actual patients depicted